Initial Launch of Stem Cell-Based Skin Care Products, International Stem Cell (ISCO.OB)
ISCO.OB launched its innovative line of topical skin care products
by their wholly-owned subsidiary, Lifeline Skin Care ™. The initial launch of the serums is to a pre-existing list of interested parties.
Containing extracts from human “parthenogenetic” stem cells (hpSC), the products were formulated by a team of ISCO’s research scientists in collaboration with cosmetic formulation experts to create an advanced scientific approach to skin care.
- The patent pending serums, which come in separate formulations for day and night time use, have been safety tested by highly regarded, independent laboratories and have been shown to promote anti-aging of the skin;
- A key innovation in creating the Lifeline Skin Care™ serums was the encapsulation of the parthenogenetic stem cell extracts into nanospheres, which not only protect the proteins, but substantially enhance the effectiveness of the serums;
The new skin rejuvenation serums are based on the breakthrough discovery that certain proteins derived from ISCO’s proprietary pluripotent human parthenogenetic stem cells are beneficial to the culture of human skin cells in the laboratory.(www.lifelineskincare.com).
Categories: Lifeline Skin Care ™., NASDAQ: ISCO.OB, Stem Cell Technology
